Menu Close

Unlocking human potential

Evolving psychedelic therapies to unlock healing and restore brain function. Breakthrough approaches to overcome neurological trauma.

Transforming Patient Outcomes

Ninnion leverages the power of AI Drug Discovery to deliver the future of novel psychedelic drug therapies optimized to restore functionality and enhance the lives of patients suffering from stroke, brain injury, chronic pain, inflammation, and addiction.

explore our solutions

Problem
Brain Injury and Stroke

A traumatic brain injury causes damage to the brain and can have serious long-term effects.

Solution
Brain Injury

With the help of some psychedelic medications, individuals can find respite for their condition and symptoms.

Problem
Inflammation

Psychedelic substances can provide relief for many conditions, including inflammation.

Solution
Inflammation

To learn how our research can improve your way of life, contact ninnion today.
Ninnion Chronic Pain

Problem
Chronic Pain

Millions of people in the United States have suffered from chronic pain, preventing them from living out their dreams.

Solution
Chronic Pain

We're testing psychedelic substances to provide relief, allowing our patients to thrive.
Ninnion addiction

Problem
Addiction

Unfortunately, millions of men and women suffer from substance use disorder.

Solution
Addiction

However, research shows that some psychedelics can assist in providing lasting recovery.

Who Is Ninnion?

We’re a group of pharmaceutical professionals and scientists pioneering the future of entheogenic drug development. We are on a mission to develop treatments for neurological diseases, initially focused on brain trauma and stroke. We have a pipeline of proprietary drug candidates and unique treatment protocols to bring to FDA approval. To Learn more about our leadership and bold innovations in an industry poised for massive growth and opportunity, please contact Ninnion today. 

View Our Approach

We have the right people for the right reasons.

Our interdisciplinary team of drug discovery and development veterans, key opinion leaders, and neurological health experts were assembled to provide innovative solutions to these challenges. With over a century of combined experience in pharmaceutical product development and commercialization, we have the know-how and the passion to create a better approach to treating neurological trauma and diseases

Meet our CEO
ninnion staff

Executive Team
Jeremy Caudill

“One good way to understand a complex system is to disturb it and then see what happens.”
Michael Pollan
Michael PollanAmerican Author
"For many years now, the CNS space has seen a type of stagnation in the development of new drugs. The movement to develop psychedelic pharmaceutical therapeutics represents a seismic shift that will significantly change the way we treat CNS disorders forever. I am excited to be a part of that movement and apply my experience to bring these drugs to regulatory approvals."
Dr. Bill W. Massey
Dr. Bill W. MasseyCDO
Previous
Next